Sodium Oxybate
Active ingredient: Sodium Oxybate
In short: Sodium oxybate oral solution is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.
What is Sodium Oxybate used for?
Sodium oxybate oral solution is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.
âš Boxed warning (FDA's strongest warning)
Central Nervous System Depression
Sodium oxybate is a CNS depressant. In clinical trials at recommended doses, obtundation and clinically significant respiratory depression occurred in adult patients treated with sodium oxybate oral solution . Many patients who received sodium oxybate oral solution during clinical trials in narcolepsy were receiving central nervous system stimulants .
Abuse and Misuse
Sodium oxybate is the sodium salt of gamma-hydroxybutyrate (GHB). Abuse or misuse of illicit GHB, either alone or in combination with other CNS depressants, is associated with CNS adverse reactions, including seizure, respiratory depression, decreases in the level of consciousness, coma, and death .
Because of the risks of CNS depression and abuse and misuse, sodium oxybate oral solution is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Sodium Oxybate REMS Program .
Sodium Oxybate dosage
The recommended starting dosage is 4.5 grams (g) per night administered orally, divided into two doses: 2.25 g at bedtime and 2.25 g taken 2.5 to 4 hours later . Increase the dosage by 1.5 g per night at weekly intervals (additional 0.75 g at bedtime and 0.75 g taken 2.5 to 4 hours later) to the effective dosage range of 6 g to 9 g per night orally. The dosage may be gradually titrated based on efficacy and tolerability. Doses higher than 9 g per night have not been studied and should not ordinarily be administered.
If a Patient’s Total Nightly Dose is: | Take at Bedtime: | Take 2.5 to 4 Hours Later:
4.5 g per night | 2.25 g | 2.25 g
6 g per night | 3 g | 3 g
7.5 g per night | 3.75 g | 3.75 g
9 g per night | 4.5 g | 4.5 g
Sodium oxybate oral solution is administered orally twice nightly. The recommended starting pediatric dosage, titration regimen, and maximum total nightly dosage are based on patient weight, as specified in Table 2. The dosage may be gradually titrated based on efficacy and tolerability.
Table 2: Recommended Pediatric Sodium oxybate oral solution Dosage for Patients 7 Years of Age and Older*
Patient Weight | Initial Dosage | Maximum Weekly Dosage Increase | Maximum Recommended Dosage
Take at Bedtime: | Take 2.5 to 4 Hours Later: | Take at Bedtime: | Take 2.5 to 4 Hours Later: | Take at Bedtime: | Take 2.5 to 4 Hours Later:
<20 kg** | There is insufficient information to provide specific dosing recommendations for patients who weigh less than 20 kg.
20 kg to <30 kg | ≤1 g | ≤1 g | 0.5 g | 0.5 g | 3 g | 3 g
30 kg to <45 kg | ≤1.5 g | ≤1.5 g | 0.5 g | 0.5 g | 3.75 g | 3.75 g
≥45 kg | ≤2.25 g | ≤2.25 g | 0.75 g | 0.75 g | 4.5 g | 4.5 g
* For patients who sleep more than 8 hours per night, the first dose of sodium oxybate oral solution may be given at bedtime or after an initial period of sleep.
**If sodium oxybate oral solution is used in patients 7 years of age and older who weigh less than 20 kg, a lower starting dosage, lower maximum weekly dosage increases, and lower total maximum nightly dosage should be considered.
Note: Some patients may achieve better responses with unequal doses at bedtime and 2.5 to 4 hours later.
The total nightly dosage of sodium oxybate oral solution is divided into two doses. Prepare both doses of sodium oxybate oral solution prior to bedtime. Prior to ingestion, each dose of sodium oxybate oral solution should be diluted with approximately ¼ cup (approximately 60 mL) of water in the empty pharmacy containers provided.
Take the first nightly dose of sodium oxybate oral solution at least 2 hours after eating
. Take the second nightly dose 2.5 to 4 hours after the first dose. …
How to take Sodium Oxybate — instructions & advice from the label
Advise the patient and/or caregiver to read the FDA-approved patient labeling (Medication Guide and Instructions for Use).
Central Nervous System Depression
Inform patients and/or caregivers that sodium oxybate oral solution can cause central nervous system depression, including respiratory depression, hypotension, profound sedation, syncope, and death. Instruct patients to not engage in activities requiring mental alertness or motor coordination, including operating hazardous machinery, for at least 6 hours after taking sodium oxybate oral solution. Instruct patients and/or their caregivers to inform their healthcare providers of all the medications they take .
Abuse and Misuse
Inform patients and/or caregivers that the active ingredient of sodium oxybate oral solution is gammaÂhydroxybutyrate (GHB), which is associated with serious adverse reactions with illicit use and abuse .
Sodium Oxybate REMS Program
Sodium oxybate oral solution is available only through a restricted program called the Sodium Oxybate REMS Program . …
Warnings & precautions
Do not take this medicine if: Sodium oxybate oral solution is contraindicated for use in:
combination with sedative hypnotics .
combination with alcohol .
patients with succinic semialdehyde dehydrogenase deficiency .
Sodium oxybate is a central nervous system (CNS) depressant. In adult clinical trials at recommended doses, obtundation and clinically significant respiratory depression occurred in patients treated with sodium oxybate oral solution. Sodium oxybate oral solution is contraindicated in combination with alcohol and sedative hypnotics. The concurrent use of sodium oxybate oral solution with other CNS depressants, including but not limited to opioid analgesics, benzodiazepines, sedating antidepressants or antipsychotics, sedating anti-epileptic drugs, general anesthetics, muscle relaxants, and/or illicit CNS depressants, may increase the risk of respiratory depression, hypotension, profound sedation, syncope, and death. If use of these CNS depressants in combination with sodium oxybate oral solution is required, dose reduction or discontinuation of one or more CNS depressants (including sodium oxybate oral solution) should be considered. In addition, if short-term use of an opioid (e.g., post- or perioperative) is required, interruption of treatment with sodium oxybate oral solution should be considered.
Healthcare providers should caution patients about operating hazardous machinery, including automobiles or airplanes, until they are reasonably certain that sodium oxybate oral solution does not affect them adversely (e.g., impair judgment, thinking, or motor skills). Patients should not engage in hazardous occupations or activities requiring complete mental alertness or motor coordination, such as operating machinery or a motor vehicle or flying an airplane, for at least 6 hours after taking sodium oxybate oral solution. …
Sodium Oxybate side effects
The following clinically significant adverse reactions appear in other sections of the labeling:
CNS depression
Abuse and Misuse
Respiratory Depression and Sleep-Disordered Breathing
Depression and Suicidality
Other Behavioral or Psychiatric Adverse Reactions
Parasomnias
Use in Patients Sensitive to High Sodium Intake
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
Adult Patients
Sodium oxybate oral solution was studied in three placebo-controlled clinical trials (Trials N1, N3, and N4, described in Sections 14.1 and 14.2) in 611 patients with narcolepsy (398 subjects treated with sodium oxybate oral solution, and 213 with placebo). A total of 781 patients with narcolepsy were treated with sodium oxybate oral solution in controlled and uncontrolled clinical trials.
Section 6.1 and Table 4 present adverse reactions from three pooled, controlled trials (N1, N3, N4) in patients with narcolepsy.
Adverse
Reactions Leading to Treatment Discontinuation:
Of the 398 patients with narcolepsy treated with sodium oxybate oral solution, 10.3% of patients discontinued because of adverse reactions compared with 2.8% of patients receiving placebo. The most common adverse reaction leading to discontinuation was nausea (2.8%). …
Drug interactions
Sodium oxybate oral solution is contraindicated for use in combination with alcohol or sedative hypnotics. Use of other CNS depressants may potentiate the CNS-depressant effects of sodium oxybate oral solution .
Concomitant use of sodium oxybate oral solution with divalproex sodium results in an increase in systemic exposure to GHB, which was shown to cause a greater impairment on some tests of attention and working memory in a clinical study . An initial dose reduction of sodium oxybate oral solution is recommended when used concomitantly with divalproex sodium . Prescribers are advised to monitor patient response closely and adjust dose accordingly if concomitant use of sodium oxybate oral solution and divalproex sodium is warranted.
About this medicine
Sodium oxybate, a CNS depressant, is the active ingredient in sodium oxybate oral solution. The chemical name for sodium oxybate is sodium 4-hydroxybutyrate. The molecular formula is C4H7NaO3, and the molecular weight is 126.09 g/mole. The chemical structure is:
Sodium oxybate is a white to off-white, powder that is very soluble in aqueous solutions. Each mL of sodium oxybate oral solution contains 0.5 g of sodium oxybate (equivalent to 0.413 g/mL of oxybate) in USP Purified Water, neutralized to pH 7.5 with malic acid.
How it works: Sodium oxybate oral solution is a CNS depressant. The mechanism of action of sodium oxybate oral solution in the treatment of narcolepsy is unknown. Sodium oxybate is the sodium salt of gamma-hydroxybutyrate (GHB), an endogenous compound and metabolite of the neurotransmitter GABA.
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 5dcf9a5c-312b-420b-82f3-42177d8f9ee4. Read the full official label on DailyMed.
Related medicines
Tirzepatide Buspirone Venlafaxine Zolpidem Citalopram Lorazepam Temazepam Melatonin